Related Experiment Video
Updated: Oct 25, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
Stefania L Calvisi1, Giuseppe A Ramirez2, Marina Scavini3
1Unit of General Medicine and Advanced Care, IRCCS Ospedale San Raffaele, Milan, Italy.
Insights
Patients with diabetes or stress hyperglycemia face higher risks of blood clots and poor outcomes from COVID-19 pneumonia. These individuals may benefit from enhanced prophylactic anticoagulation strategies.
Area of Science:
- Internal Medicine
- Cardiology
- Endocrinology
Background:
- Diabetes and stress hyperglycemia are known risk factors for adverse outcomes in patients with SARS-CoV-2 infection.
- The role of thromboembolic complications in this increased risk remains to be fully elucidated.
Purpose of the Study:
- To investigate whether an increased risk of thromboembolic complications modulates the adverse clinical outcome in patients with diabetes/stress hyperglycemia and COVID-19 pneumonia.
- To analyze the association between diabetes/stress hyperglycemia and thromboembolic events in hospitalized COVID-19 patients.
Main Methods:
- Prospective follow-up of 169 hospitalized patients with confirmed COVID-19 pneumonia.
- Analysis of inflammation, tissue damage biomarkers, hemostatic parameters, thrombotic events (TEs), and clinical outcomes.
- Stratification of patients based on the presence of diabetes/stress hyperglycemia and fasting blood glucose levels.
Main Results:
- Diabetes/stress hyperglycemia was associated with increased inflammation, tissue damage markers, higher D-dimer, prolonged prothrombin time, and lower antithrombin III activity.
- Diabetes/stress hyperglycemia, fasting blood glucose, and glucose variability significantly increased the risk of thromboembolic complications.
- Thromboembolic events heightened the risk of adverse clinical outcomes specifically in patients with diabetes/stress hyperglycemia or elevated fasting blood glucose.
Conclusions:
- Thromboembolism risk is elevated in COVID-19 pneumonia patients with diabetes/stress hyperglycemia, contributing to poor clinical outcomes.
- Consideration for more intensive prophylactic anticoagulation is warranted for SARS-CoV-2 infected patients with diabetes/stress hyperglycemia.
Purpose:
Individuals with diabetes/stress hyperglycemia carry an increased risk for adverse clinical outcome in case of SARS-CoV-2 infection. The purpose of this study was to evaluate whether this risk is, at least in part, modulated by an increase of thromboembolic complications.
Methods:
We prospectively followed 180 hospitalized patients with confirmed COVID-19 pneumonia admitted to the Internal Medicine Units of San Raffaele Hospital. Data from 11 out of 180 patients were considered incomplete and excluded from the analysis. We analysed inflammation, tissue damage biomarkers, hemostatic parameters, thrombotic events (TEs) and clinical outcome according to the presence of diabetes/stress hyperglycemia.
Results:
Among 169 patients, 51 (30.2%) had diabetes/stress hyperglycemia. Diabetes/stress hyperglycemia and fasting blood glucose (FBG) were associated with increased inflammation and tissue damage circulating markers, higher D-dimer levels, increased prothrombin time and lower antithrombin III activity. Forty-eight venous and 10 arterial TEs were identified in 49 (29%) patients. Diabetes/stress hyperglycemia (HR 2.71, p = 0.001), fasting blood glucose (HR 4.32, p < 0.001) and glucose variability (HR 1.6, p < 0.009) were all associated with an increased risk of thromboembolic complication. TEs significantly increased the risk for an adverse clinical outcome only in the presence of diabetes/stress hyperglycemia (HR 3.05, p = 0.010) or fasting blood glucose ≥7 mmol/L (HR 3.07, p = 0.015).
Conclusions:
Thromboembolism risk is higher among patients with diabetes/stress hyperglycemia and COVID-19 pneumonia and is associated to poor clinical outcome. In case of SARS-Cov-2 infection patients with diabetes/stress hyperglycemia could be considered for a more intensive prophylactic anticoagulation regimen.
More Related Videos
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Venous Thrombosis I: Introduction
Pulmonary Embolism III: Nursing Management
Diabetes: Symptoms, Diagnosis, and Complications
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care